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Akabori 2 highlights 
- Substituted benzaldehydes convert into pseudoephedrines
- Electronic influence of the substituent on reaction outcomes were minor
- Molecular modelling provides insight into substituents lack of influence
- Sub-optimal reaction conditions with p-methoxy benzaldehyde produce new by-products
- Stereochemical purity of products rationalised by molecular modelling
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Detailed Investigations into the Akabori-Momotani reaction for the Synthesis 
of Amphetamine Type Stimulants: Part 2 
 
 
Abstract 
The Akabori-Momotani reaction can be used to synthesise pseudoephedrine in 50% yield from N-
methylalanine and benzaldehyde. This paper investigates electronic effects of substituted 
benzaldehydes on the reaction to synthesise amphetamine type stimulants and identifies several 
new Akabori-Momotani by-products, 1-[(4-methoxybenzyl)(methyl)amino]ethanol (11c), 2-(4-
methoxyphenyl)-3,4-dimethyl-1,3-oxazolidine (12c), 1,2,3,4-tetramethyl-5,6-di-(4-
methoxyphenyl)piperazine (13c) and 1,2,4,5-tetramethyl-3,6-di-(4-methoxyphenyl)piperazine (14c). 
This paper also investigates pseudoephedrine and methamphetamine isomeric distribution from the 
Akabori-Momotani reaction with the aid of molecular modelling to understand why more 
pseudoephedrine than ephedrine is produced. 
 
Introduction  
With the wealth of knowledge surrounding traditional methods employed by clandestine 
laboratories for the synthesis of amphetamine type stimulants (ATS), “clan lab cooks” have turned 
their attention to more novel synthetic strategies that circumvent precursor legislation. One of these 
novel methods is the Akabori-Momotani reaction and we have recently reported [1, 2] the 
importance of this pathway in ATS production. Further, isotope and stereochemical profiling of 
ephedrine synthesised via this method has recently been reported [3]. The reaction was established 
in 1943 by Japanese chemists Akabori and Momotani [4], where N-methylalanine 1 was allowed to 
react with benzaldehyde 2a and produced a mixture of pseudoephedrine and ephedrine 5a in 16% 
yield. The initial reaction proceeds via an azomethine ylide 3a intermediate which reacts with a 
dipolarophile (benzaldehyde 2a) in a 1,3-dipolar cycloaddition to form an oxazolidine 4a. Through 
optimisation of reaction conditions we have been able to raise the yield of oxazolidine to 50% with 
subsequent acidic hydrolysis forming pseudoephedrine and ephedrine 5a in 80% yield (Scheme 1) 
[1]. 
There are very few recent reports referencing the Akabori-Momotani reaction directly in the 
literature. This can be attributed to the fact that this chemistry is normally reported as a 1,3-dipolar 
cycloaddition or azomethine ylide chemistry where the oxazolidine is isolated rather than hydrolysed 
to the amino alcohol [5-8]. In this paper we commonly isolate the oxazolidine rather than the amino 
alcohol. It is therefore more accurate to refer to these reactions as 1,3-dipolar cycloaddition 
reactions, with the one pot reactions incorporating an in situ acid hydrolysis step as Akabori-
Momotani reactions. However, since this chemistry is referred to in the forensic community as the 
Akabori-Momotani reaction we have continued that designation here. Whilst the Akabori-Momotani 
reaction has been published in the literature for a number of years, its use for the production of 
pseudoephedrine is a relatively recent development, with Forensic Science SA first encountering a 
clandestine laboratory employing this chemistry in 2011. 
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Scheme 1 Synthesis of substituted pseudoephedrine/ephedrine isomers 5a-g from N-methylalanine 1 and 
substituted benzaldehydes 2a-g by the Akabori-Momotani reaction. 
 
Our most recent publications on the Akabori-Momotani reaction for the production of ATS 
investigated the effect of different reaction conditions and sources of N-methylalanine as well as  
tentatively identifing the resulting by-products by GC-MS [1]. We report herein our investigations 
into the electronic effects of substituted benzaldehydes, and our rationalisation of isomer 
distribution (pseudoephedrine/ephedrine) with the aid of molecular modelling. 
 
Results and discussion 
Substituted benzaldehydes 
Many different substituted benzaldehydes 2a-g were used in the Akabori-Momotani reaction and 
the crude yields of oxazolidines 4a-g from the various reactions can be seen in Table 1. There was no 
trend observed between electronic effects of the substituent (from electron donating b, c, d to 
electron withdrawing e, f, g and the yield of oxazolidine 4a-g or pseudoephedrine/ephedrine 5a-g 
(Table 1). In only one case (g) were anomalous results observed and these are discussed further 
below. 
 
Table 1 Yields of substituted pseudoephedrine/ephedrine 5a-g from the Akabori-Momotani reaction. 
Compound R group Yield of 4 
(%) 
Yield of 5 
over two steps (%) 
HOMO-LUMO 
gap (eV) 
Activation energy 
(kJmol
-1
) 
b
 
a H 50 33 2.16 72 
b 4-Me 34 25 2.15 74 
c 4-OMe 43 38 2.23 73 
d 3,4-O2CH2 44 39 2.19 70 
e 4-Cl 47 26 2.06 72 
f 4-F 52 39 2.11 71 
g 4-NO2 35
a 9 1.51 81 
a yield is for the formation of aziridine 15g and not oxazolidine 4g. 
b the transition states modelled may not be the exact transition states the reaction proceeds through. However it is a 
consistent transition state between the different substituents to show the trend in activation energy. 
 
This observation is inconsistent with previous reports in which the reaction between benzaldehyde 
2a and N-methylalanine 1 yielded pseudoephedrine/ephedrine 5a in 48% in a one pot reaction but 
when 4-methoxybenzaldehyde 2c or piperonal 2d were used the yields reported were 72 and 87% 
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respectively [9, 10]. However, the reports are a conference abstract only and no publication has 
appeared in literature. 
 
In an effort to understand the lack of effect from the substituent we examined the reaction of the 
compounds using molecular modelling at DFT level. In particular, the HOMO and LUMO energies for 
the various species were calculated. The mechanism of the Akabori-Momotani reaction is a 1,3-
dipolar cycloaddition consisting of an overlap between the LUMO of a dipolarophile (in this case the 
benzaldehyde 2a-g) and the HOMO of the dipole (the azomethine ylide 3a-g) (Scheme 2). Normally 
when an electron withdrawing group is attached to the benzaldehyde the energy of the LUMO will 
be lowered resulting in a greater overlap with the HOMO of the dipole increasing reactivity. 
However, in our system the dipole (azomethine ylide 3a-g) is generated from the same 
benzaldehyde, so the electron withdrawing group would also be present in the azomethine ylide 3a-
g, lowering the energy of the dipole HOMO resulting in reduced overlap between orbitals hence 
decreasing reactivity. Thus, any electronic effect of the substituent that increases the reactivity of 
dipolarophiles will also decrease the reactivity of the dipole, meaning that electronic effects of the 
substituent may not affect the reaction as much as one would expect. This is evidenced by the 
calculated individual HOMO and LUMO energy levels which change as a result of the substituent, yet 
the HOMO-LUMO gap is only slightly altered (Table 1, ESI Table 1). 
 
 
Scheme 2 Reaction of the different resonance forms of the azomethine ylide (A and B) to produce either 
oxazolidine 4a-g or 10a-g and subsequent hydrolysis to yield amino alcohols 9a-g or 5a-g. 
 
The activation energy for 1,3-dipolar cycloaddition reaction was also calculated and the results are 
collated in Table 1. As shown by the values obtained there was no observable trend between the 
electronic influence of the substituent and the activation energies calculated. However, an 
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anomalous result for the nitro substituted material was again observed. Thus combining the HOMO-
LUMO results with the activation energy calculations, it would be expected that the influence of the 
substituent on reactivity would be minimal, which is consistent with our experimental results. 
 
We next turned our attention to the examination of by-products formed during the Akabori-
Momotani reaction of substituted benzaldehydes. The reactivity of the substituted benzaldehydes 
2a-g were similar to benzaldehyde 2a, [1]. For one substituent (4-methoxy, 2c, chosen in part due to 
forensic significance) we carried out the reaction under sub-optimal conditions [1] to maximise by-
product formation. The GC-MS trace is shown in Figure 1, with identified by-products shown in Table 
2. 
 
The GC-MS trace contains several expected peaks namely residual aldehyde 2c, unhydrolysed 
oxazolidine 4c, pseudo/ephedrine product 5c. In addition, there are numerous smaller by-product 
peaks and these will now be discussed. 7a, 8a, 9a and 10a (R=H) have been previously detected [1] 
so the observation of 4-methoxy analogues 7c, 8c, 9c and 10c was expected. Formation of 8c is 
particularly difficult to rationalise and we are currently investigating how this may arise. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Partial GC-MS trace showing the typical by-products from a Akabori-Momotani reaction between 4-
methoxybenzaldehyde 2c and N-methylalanine 1. 
 
The next by-product, 11c, has been assigned from the GC-MS data, with the only major fragment 
(121 m/z) being a commonly observed fragment in the mass spectrometry of this work. Since no 
molecular ion was assigned for 11c this assignment is uncertain. However, this type of by-product is 
2c 
7c 
8c 
5c, 
12c 
9c 
4c 
11c 
13c 
14c 
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known to occur in 1,3-dipolar cycloaddition reactions [8]; in this case 11c arises from the reaction 
between azomethine ylide 3c and water. 
 
4-Methoxypseudoephedrine 5c co-eluted with an oxazolidine by-product 12c as evidenced by the 
presence of ions derived from 12c in combination with those normally seen for 5c. No adjustment of 
GC-MS conditions was carried out to separate these compounds. Oxazolidines of this type (eg R=H, 
12a) have previously been seen in clandestine literature from the reaction between 
pseudoephedrine and formaldehyde [11] and thus the detection of 12c is in line with this 
observation. In this case though the origin of the formaldehyde is not clear. The next by-products are 
regioisomers 13c and 14c, which are formed from the cyclisation between two molecules of 
azomethine ylide 3c, another by-product type known to arise from 1,3-dipolar cycloaddition 
reactions [5, 12]. 
 
Table 2 Identity and mass spectra for compounds identified in Figure 1. 
Number Structure Mass spectrum 
2c 
O
H
O
Chemical Formula: C8H8O2
Monoisotpic Mass:136.05  
 
7c 121
44
O
N
H
Chemical Formula: C9H13NO
Monoisotpic Mass: 151.10
 
 
11c 
178164
121
O
N
OH
Chemical Formula: C11H17NO2
Monoisotpic Mass:195.13
 
 
8c 
N
H
O
162
14744
Chemical Formula: C11H15NO
Monoisotpic Mass: 177.12
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5c  
 
 
 
 
 
 
12c  
OH
HNO
58
Chemical Formula: C11H17NO2
Monoisotpic Mass:195.13
 
 
O
N
O
Chemical Formula: C12H17NO2
Monoisotpic Mass: 207.13
56177
136
 
 
 
9c 
N
H
OH
O
O
270
120
150
137
Chemical Formula: C17H21NO3
Monoisotpic Mass: 287.15
  
13c 
N
N
O
O
150
269
Chemical Formula: C22H30N2O2
Monoisotpic Mass: 354.23
  
14c 
N
N
O
O162
162
Chemical Formula: C22H30N2O2
Monoisotpic Mass: 354.23
  
4c 
N
O
O
O
176
135
Chemical Formula: C19H23NO3
Monoisotpic Mass: 313.17   
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Many of the by-products which were identified for the 4-methoxy substituted compounds were also 
tentatively identified by GC-MS for the other substituents. However, these by-products were only 
observed in traces amounts due to reactions being performed under optimised conditions. No sub-
optimal reaction conditions were examined for substituents other than 4-methoxy. In addition, by-
products of type 13 and 14 were not seen for any other substituent which is likely due to the 
equivalent of benzaldehydes used in the reaction. 
 
As mentioned previously, one substituted benzaldehyde was observed to result in a particularly low 
yield of substituted pseudoephedrine/ephedrine, namely the 4-nitrobenzaldehyde 2g. In this 
instance the 4-nitro substituted oxazolidine 4g was not observed but rather a substituted aziridine 
15g was tentatively identified by GC-MS (ESI figure 5). The aziridine ring forms as a result of an 
intramolecular cyclisation within the azomethine ylide (Scheme 3). The ring opening reaction of 
aziridines is a common in situ source of azomethine ylides when performing 1,3-dipolar 
cycloadditions [5]. Hydrolysis of aziridine 15g yields 4-nitro pseudoephedrine/ephedrine 5g (ESI 
figure 6). 4-Nitro derivatised aziridine 15g was the only substituent for which the aziridine 
compound was detected. If other substituted derivatives formed aziridines, they would be expected 
to be volatile compounds and it is possible that they were lost during reaction and/or workup. 
Current investigations are examining this later possibility utilising sealed tubes to contain any 
aziridines that may form during the reaction. 
O2N
N
O2N
N
O2N
OH
HN
H+
H2O
3g 15g 5g  
Scheme 3 Formation of 4-nitro aziridine 15g from 3g and subsequent hydrolysis to 4-nitro 
pseudoephedrine/ephedrine 5g. 
 
The 4-fluoro substituent is also noteworthy as a large amount of 9f was detected in the product 
mixture by GC-MS (ESI Figure 7).1 This diaromatic compound 9f was reduced under standard 
hypophosphorous acid / iodine reduction conditions to 16f (Scheme 4, ESI Figure 8). We are 
currently investigating the use of other amino acids in the Akabori-Momotani reaction where the 
question of selectivity towards the two different ylide structures (A and B) in Scheme 2 is important. 
We are also investigating the factors within the azomethine ylide which lead to the two different 
ylide structures.  
 
OH
N
H
N
H
I2, H3PO2
F
F
F
F
9f 16f  
                                                           
1 Surprisingly the 4-Cl substituted 2e did not produce any detectable amounts (by GC-MS) of the corresponding 
diaromatic 9e (ESI Figure 9). 
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Scheme 4 Reduction of 9f under standard hypophosphorous acid / iodine reduction conditions to yield 16f. 
 
Surprisingly the 4-Cl substituted 2e did not produce any detectable amounts (by GC-MS) of the 
corresponding diaromatic 9e (ESI Figure 9). 
 
Stereochemical purity 
The stereochemical purity of clandestinely manufactured pseudoephedrine and methamphetamine 
can be used as an indication of possible sources and/or routes of manufacture [13]. The 
diastereomeric ratio of pseudoephedrine to ephedrine is easily determined by 1H NMR since the C1 
proton resonance exhibits a characteristic chemical shift and coupling constants for each material. 
Subsequent conversion of the pseudoephedrine / ephedrine mixture to methamphetamine results in 
the loss of the C1 stereochemistry, producing enantiomers for which NMR is unable to be used to 
determine stereochemical purity. Consequently, the enantiomeric ratio of d- to l-methamphetamine 
was determined by using a chiral derivatising agent (S)-(−)-N-(trifluoroacetyl)-pyrrolidine-2-carbonyl 
chloride (TPC) followed by GC-MS analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 Partial 1H NMR spectrum from the hydrolysis of an Akabori-Momotani reaction performed under 
optimised conditions [1], which shows the ratio of pseudoephedrine to ephedrine produced. The minor signals 
shown in the spectrum are from un-hydrolysed oxazolidine 4a.  
 
The stereochemical purity of the pseudoephedrine/ephedrine mixture 5a from the Akabori-
Momotani reaction was determined and found to be temperature dependant. In particular, at high 
temperatures (160˚C) the diastereomeric ratio was 60:40 while at a lower temperature (60˚C) the 
ratio was 65:35, with more pseudoephedrine than ephedrine always detected (Figure 2). After a 
standard hypophosphorous acid / iodine reduction to methamphetamine the enantiomeric ratio of 
HN
OHH
HN
OHH
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d- to l-methamphetamine was determined to be 45:552 (Figure 3); this ratio was observed not to be 
influenced by temperature. 
 
The ratio of isomers in the pseudoephedrine/ephedrine mixture is unusual as the pseudoephedrine 
sourced from pharmaceutical preparations has a ratio 100:0, biosynthetic sourced pseudoephedrine 
(through l-PAC) has a ratio of 26:74 [14] and synthetically produced (from 1-phenylpropan-1-one) 
[15, 16] has a ratio of 50:50. (+)-Pseudoephedrine and (-)-ephedrine can also be sourced naturally by 
their extraction from the Ephedra species. Thus molecular modelling was undertaken to investigate 
this unusual distribution of isomers in the pseudoephedrine/ephedrine mixture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Partial GC-MS trace of methamphetamine from the Akabori-Momotani pathway that has been 
derivatised with TPC. 
 
Understanding the stereochemical purity 
In the hydrolysis of oxazolidine 4a to pseudoephedrine 5a it was assumed that stereochemistry is 
retained. To test this assumption several experiments were undertaken. Firstly, pure 
pseudoephedrine was heated under reflux in 10% acetic acid hydrolysis conditions to determine if 
any racemisation occurred. No racemisation was detected by 1H NMR even when higher 
concentrations of acetic acid (50%) were used. Secondly, oxazolidine 4a was synthesised from pure 
pseudoephedrine and benzaldehyde (Scheme 5, ESI figure 3) and only one diastereomer was 
detected by 1H NMR. This oxazolidine retained the stereochemistry of the initial pseudoephedrine, 
with this assignment being supported by a NOESY NMR experiment. The hydrolysis of this 
oxazolidine produced only pseudoephedrine, with no ephedrine detected by 1H NMR (ESI figure 4). 
The stereochemistry of pseudoephedrine/ephedrine 5a is a result of the formation of oxazolidine 4a 
and therefore molecular modelling of the formation of oxazolidine 4a will give insight to the 
                                                           
2 This ratio is an estimate based upon the area of the peaks seen in the GC-MS. However, as the peaks in the 
GC-MS overlap slightly due to the typical tail associated with pseudoephedrine type compounds this ratio 
represents an overestimation of the amount of d-methamphetamine present. 
l-meth 
d-meth 
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distribution of isomers in pseudoephedrine/ephedrine 5a produced by the Akabori-Momotani 
reaction. 
 
 
Scheme 5 Synthesis of oxazolidine 4a from pure pseudoephedrine 5a and subsequently hydrolysis back to 4a. 
The main correlations from the NOESY experiment supporting the assignment of stereochemistry for 
oxazolidine 4a are shown by green arrows. Distances between hydrogens shown are calculated from molecular 
modelling. 
 
The distribution of isomers in pseudoephedrine/ephedrine 5a produced in the Akabori-Momotani 
reaction is determined by several factors. Firstly, the geometry and face of reaction of the 
azomethine ylide 3a where there are four possible geometries (Figure 4), which will determine 
relative stereochemistry of stereocentres (SC) 1 and 2 (Figure 4). The face of the ylide on which 
reaction occurs will determine the absolute stereochemistry of stereocentres 1 and 2. Secondly, the 
face of benzaldehyde 2a that undergoes the 1,3-dipolar cycloaddition will determine the 
stereochemistry at the benzyl position in pseudoephedrine/ephedrine namely SC3.  
 
 
 
Figure 4 Four possible geometries of azomethine ylide 3a, and three stereocenters (SC) in the oxazolidine 4a. 
SC1 is lost in the hydrolysis of the oxazolidine to pseudoephedrine/ephedrine, whereas SC3 is lost in the 
reduction to methamphetamine. 
 
There are two orientations, shown in Scheme 2, through which benzaldehyde 2a and the ylide 3a 
can undergo a 1,3-dipolar cycloaddition to form oxazolidines 4a and 10a. In total, there are thirty 
two different combinations of faces of benzaldehyde and ylide face and geometries in which the 
azomethine ylide 3a and benzaldehyde 2a can react. Table 3 details sixteen different geometric 
combinations of the azomethine ylide 3a and benzaldehyde 2a resulting in every possible isomer of 
4a and 10a which is shown in the various SC combinations. In addition, for each entry there is a 
mirror image transition state which leads to the completely inverted stereochemistry. This mirror 
image transition state results from the opposite face of the ylide reacting with opposite face of 
benzaldehyde. Figure 5 details two of thirty two different ways the azomethine ylide 3a and 
benzaldehyde 2a can react where the reaction shown is entry 3 from table 3 and is its mirror image 
transition state. Modelling of this mirror image transition state resulted in energy differences of 0-5 
Jmol-1 between the transition states. The activation energy for each route has been determined 
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using molecular modelling allowing a comparison of likely reaction routes. The activation energy for 
the 1,3-dipolar cycloaddition calculated in this study is approximately 80 kJmol-1, which is 
comparable to literature barriers for 1,3-dipolar cycloadditions [17-19]. The possibility of the 
reaction occurring via stepwise mechanisms [20] was also examined theoretically but the barriers 
calculated were unreasonable3.  
                                                           
3 A stepwise mechanism for this reaction proceeds via an intermediate with a triplet spin state. Attempts were 
made to model a stepwise mechanism that goes through an intermediate with a singlet spin state but no 
stationary points located correspond to this mechanism. 
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 Figure 5 Transition state and resultant oxazolidine from the reaction between azomethine ylide 3a 
and benzaldehyde 2a; A) entry 3 (Table 3), B) mirror image transition state to entry 3 Table 3. 
 
The ylide with the smallest activation energy for the reaction (entry 9, Table 3) would lead to 
oxazolidine 10a, which is a minor by-product as opposed to the major isomer 4a. This small 
activation barrier results from the high energy W- geometry for azomethine ylide 3a which would be 
expected to be a minor proportion of the ylide geometries in solution. In contrast the lower energy 
ylide geometries (S2 and U) would be expected to be highly populated in solution (entries 3, 4, 7, 8, 
11, 12, 15, 16, Table 3). When combined with activation energy this leads to a preference for 4a 
2.58 Å 
2.15 Å 
SC1 = S 
SC3 = R 
SC2 = R 
2.15 Å 
SC1 = R 
SC2 = S 
SC3 = S 
2.58 Å 
A) 
B) 
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formation (entry 3, Table 3). In particular, the reaction leading to pseudoephedrine (entry 3, Table 3) 
has an activation energy 2 kJmol-1 lower in energy than that leading to ephedrine (entry 7, Table 3). 
This small difference is capable of giving slight selectivity towards one product [21] and indeed more 
pseudoephedrine is always detected than ephedrine as discussed previously. Both reactions (entries 
3 and 7, Table 3) should lead to d-methamphetamine but their mirror image transition state would 
lead to l-methamphetamine. Therefore the modelling predicts there should be no selectivity 
towards either isomer of methamphetamine. It was observed there was a slight selectivity towards l-
methamphetamine, so the modelling results do not fully explain the observed selectivity. However, 
it is known that 1,3-dipolar cycloadditions are difficult to model [21]. 
 
Table 3 Sixteen of the thirty two possible different orientations the azomethine ylide 3a and 
benzaldehyde 2a can react along with activation energy and resulting oxazolidine stereochemistry. 
Stereocenter
d
 
Entry 
Azomethine 
ylide 
(kJmol
-1
)
a
 Face
b
 Product
c
 
Activation 
energy 
(kJmol
-1
) 1 2 3 
1 W 18.1 Si 4 79 R R S 
2 S1 8.1 Si 4 77 S R S 
3 S2 1.7 Si 4 72 R S S 
4 U 0 Si 4 79 S S S 
5 W 18.1 Re 4 58 R R R 
6 S1 8.1 Re 4 73 S R R 
7 S2 1.7 Re 4 74 R S R 
8 U 0 Re 4 102 S S R 
9 W 18.1 Si 10 55 S S S 
10 S1 8.1 Si 10 75 R S S 
11 S2 1.7 Si 10 82 S R S 
12 U 0 Si 10 105 R R S 
13 W 18.1 Re 10 61 S S R 
14 S1 8.1 Re 10 68 R S R 
15 S2 1.7 Re 10 86 S R R 
16 U 0 Re 10 94 R R R 
a first column shows ylide geometry 3a, second column is ylide energy relative to the lowest energy ylide. b the face of 
benzaldehyde undergoing the 1,3-dipolar cycloaddition. c product from the 1,3-dipolar cycloaddition. d stereocentres in the 
resulting oxazolidine. 
 
 
Conclusions 
The use of substituted benzaldehydes 2a-g in the Akabori-Momotani reaction was examined and no 
trend was observed between electronic effects of the substituent and the yield achieved. The 
theoretical results from activation energy calculations of the reactions were consistent with our 
experimental results. However, in one case (R=nitro) an aziridine was produced (as opposed to an 
oxazolidine) that subsequently hydrolysed to pseudoephedrine/ephedrine mixture. 
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Examination of the by-products formed with substituted benzaldehydes compared well with the 
parent benzaldehyde. Most of the other compounds detected were in line with those expected from 
a 1,3-dipole cycloaddition reaction. 
Molecular modelling on the Akabori-Momotani reaction indicates there should be selectivity 
towards pseudoephedrine over ephedrine and no selectivity towards either isomer of 
methamphetamine. Our results always exhibited selectivity for pseudoephedrine but a very slight 
selectivity towards l-methamphetamine was observed. The selectivity could be classed as poor with 
respect to traditional areas of organic chemistry, but could be useful in the chemical profiling of ATS. 
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Experimental 
All reagents were purchased from Sigma-Aldrich (Australia). Solvents were purchased from Sigma-
Aldrich and Chemsupply. 
 
Molecular Modelling 
All calculations were performed using Gaussian09 program with all structures optimised by Density 
Functional Theory (DFT) B3LYP and 6-31G(d,p) as the basis. Frequency calculations were performed 
on all stationary points located to determine the nature of the stationary point and to correct the 
relative energies for zero point energy (ZPE) or Gibbs Free energy. All calculations were performed in 
vacuum at 298.15 K 
 
Instrumentation 
NMR spectra were recorded on either Bruker Avance III 600 or 400 MHz NMR spectrometers using 
CDCl3 as the solvent and internal lock for 
1H and 13C spectra. Chemical shifts are recorded in ppm for 
all spectra. Coupling constants (J values) are recorded in Hz. 
 
GC-MS analysis was performed on a Varian Saturn 2200. Helium was used as the carrier gas at a 
constant flow of 1.2 mL/min. with a solvent delay of 3 min.; the column was Varian DB-5 (5% phenyl 
methyl polysiloxane) 30 m × 0.25 mm × 0.25 μm film thickness. The spilt ratio was 50:1. The Injector 
temperature was 280°C, with the initial column temperature at 60˚C for 2.5 min and then ramped at 
45°C per min. to 280°C and held at 280°C for 12 minutes. The mass spectrometer operated from 40 
to 400 amu electron impact ionisation (EI) with an ionisation energy of 70 eV. 
 
GC-MS analysis for the methamphetamine derivatized with TPC was performed on an Agilent 
Technologies 7890A GC system coupled to 5975C MS. The same GC conditions to the Varian Saturn 
were used, the mass spectrometer operated from 40 to 550 amu. 
 
Synthetic procedures 
Oxazolidine analogues 4a-f, aziridine 15g 
The general procedure of the Akabori-Momotani reaction for production of the oxazolidines 4a-g is 
outlined in [1]. 
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Compound 
number 
R= Yield 
(%) 
GC retention 
time 
(mins) 
MS ions 
4a H 50 7.79 42 (5%), 51 (10%), 77(15%), 105 (25%), 
117(7%), 146 (base peak), 167 (7%), 195 (5%), 
253 (2.5%) 
4b 4-Me 34 8.29 65 (10%), 91 (15%), 119 (20%), 146 (15%), 160 
(base peak), 195 (15%), 209 (15%) 
4c 4-Cl 47 9.07 89 (15%), 139 (35%), 180 (base peak), 229 
(20%) 
4d 4-F 52 7.63 95 (15%), 123 (35%), 167 (base peak), 203 
(15%) 
4e 3,4-O2CH2 44 11.32 65 (10%), 91 (15%), 149 (35%), 190 (base peak), 
255 (50%) 
4f 4-OMe 43 9.61 77 (10%), 91 (7.5%), 121 (7.5%), 135 (25%), 176 
(base peak), 227 (40%) 
15g 4-NO2 
(Aziridine) 
35 6.37 42 (20%), 117 (50%), 147 (30%), 163 (base 
peak) 
 
Production oxazolidine 4a from pure pseudoephedrine 5a 
A mixture of pure pseudoephedrine (0.3 g, 1.8 mmol), benzaldehyde (1 g, 9 mmol) and toluene (10 
mL) was heated under reflux for 6 hours. The solution was acidified with HCl (2M), washed with 
toluene, basified with NaOH (2M) and extracted with toluene. The solution was then dried (Na2SO4) 
and the solvent was removed under vacuum. Product isolated as white solid with a yield 73%, mp 
65.3-65.8°C, GC-MS and NMR identical to previous [1]. 
 
Pseudoephedrine analogues 5a-g 
The general procedure for the hydrolysis of oxazolidine 4 to pseudoephedrine 5a-g is outlined in [1]. 
Compound 
number 
R= Yield (over 
two steps) 
(%) 
GC 
retention 
time (mins) 
MS ions 
5a H 33 6.20 51 (7%), 58 (base peak), 77(20%), 165 (5%) 
5b 4-Me 25 6.41 42 (5%), 56 (5%), 58 (base peak), 77 (10%), 
91 (20%), 119 (5%), 179 (2.5%) 
5c 4-Cl 26 6.70 42 (5%), 56 (5%), 58 (base peak), 77 (20%), 
199 (2.5%) 
5d 4-F 39 6.11 56 (5%), 58 (base peak), 77 (10%), 184 
(10%) 
5e 3,4-O2CH2 39 7.13 42 (10%), 56 (10%), 77 (10%), 149 (5%), 
192 (5%) 
5f 4-OMe 38 6.84 42 (5%), 56 (5%), 58 (base peak), 77 (10%), 
94 (5%), 109 (5%), 178 (10%) 196 (5%) 
5g 4-NO2 9 7.43 42 (5%), 51 (5%), 58 (base peak), 77 (10%) 
105 (5%) 
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105 (5%) 
 
Methamphetamine from pseudoephedrine  
A mixture of iodine (0.8 g, 3.15 mmoles), hypophosphorous acid (H3PO2) (50%, 2 g, 15.51 mmoles) 
pseudoephedrine/ephedrine 5 (0.3g, 1.88 mmoles,) was heated under reflux for 3 hours. Upon 
cooling the solution was washed with ether, the aqueous layer basified with NaOH (2M) and 
extracted with ether. Ether solution was then dried with Na2SO4 and the solvent was removed under 
vacuum. Yield 70%. 
GC: 5.486 minutes (retention time), MS: 42 (5%), 58 (base peak), 65 (10%), 91 (15%), 150 (20%). 
1H NMR (400 MHz, CHCl3): δ 7.31-7.17 (m, 5H, Ar), 2.84-2.71 (m, 2H), 2.63 (m, 1H), 2.60 (s, 3H), 1.06 
(d, 3H, J=6.2 Hz). 13C NMR (100 MHz, CHCl3): δ 139.4, 129.3, 128.4, 126.2, 56.6, 43.3, 33.8, 19.6. 
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